Xu L - Search Results

1

miRNAs as therapeutic predictors and prognostic biomarkers of neoadjuvant chemotherapy in breast cancer: a systematic review and meta-analysis.

Zhang Z, Zhang H, Yu J, Xu L, Pang X, Xiang Q, Liu Q, Cui Y. Zhang Z, et al. Among authors: xu l. Breast Cancer Res Treat. 2022 Aug;194(3):483-505. doi: 10.1007/s10549-022-06642-z. Epub 2022 Jun 21. Breast Cancer Res Treat. 2022. PMID: 35727379 Review.

2

[Prospective study on the role of MRI and B ultrasonography in evaluating the tumor response to neoadjuvant chemotherapy in breast cancer].

Ye JM, Xu L, Wang DM, Zhao JX, Zhang LB, Duan XN, Liu YH. Ye JM, et al. Among authors: xu l. Zhonghua Wai Ke Za Zhi. 2009 Mar 1;47(5):349-52. Zhonghua Wai Ke Za Zhi. 2009. PMID: 19595011 Chinese.

3

[Effects and toxicity of neoadjuvant chemotherapy with vinorelbine and cisplatin in treatment of operable breast cancer previously non-responsive to anthracyclines and taxanes-containing regimen: analysis of 19 cases].

Xu L, Ye JM, Zhao JX, Duan XN, Liu YH. Xu L, et al. Zhonghua Yi Xue Za Zhi. 2009 Mar 17;89(10):683-5. Zhonghua Yi Xue Za Zhi. 2009. PMID: 19595063 Clinical Trial. Chinese.

4

[Relationship between Ki67 expression and tumor response to neoadjuvant chemotherapy with anthracyclines plus taxanes in breast cancer].

Xu L, Liu YH, Ye JM, Zhao JX, Duan XN, Zhang LB, Zhang H, Wang YH. Xu L, et al. Zhonghua Wai Ke Za Zhi. 2010 Mar 15;48(6):450-3. Zhonghua Wai Ke Za Zhi. 2010. PMID: 20627009 Chinese.

5

Effectiveness of dynamic contrast-enhanced magnetic resonance imaging in evaluating clinical responses to neoadjuvant chemotherapy in breast cancer.

Liu YH, Ye JM, Xu L, Huang QY, Zhao JX, Duan XN, Qin NS, Wang XY. Liu YH, et al. Among authors: xu l. Chin Med J (Engl). 2011 Jan;124(2):194-8. Chin Med J (Engl). 2011. PMID: 21362364

6

Erythropoietin receptor expression and its relationship with trastuzumab response and resistance in HER2-positive breast cancer cells.

Zhang C, Duan X, Xu L, Ye J, Zhao J, Liu Y. Zhang C, et al. Among authors: xu l. Breast Cancer Res Treat. 2012 Dec;136(3):739-48. doi: 10.1007/s10549-012-2316-x. Epub 2012 Nov 2. Breast Cancer Res Treat. 2012. PMID: 23117856

7

[Effects of vinorelbine plus cisplatin as second-line neoadjuvant chemotherapy regimen in the treatment of breast cancer].

Wang J, Xu L, Ye JM, Zhao JX, Duan XN, Liu YH. Wang J, et al. Among authors: xu l. Zhonghua Yi Xue Za Zhi. 2013 Jan 8;93(2):93-5. Zhonghua Yi Xue Za Zhi. 2013. PMID: 23648342 Chinese.

8

[Factors related with pathological complete response of neoadjuvant chemotherapy in primary breast cancer].

Cheng YJ, Ye JM, Xu L, Zhao JX, Duan XN, Liu YH. Cheng YJ, et al. Among authors: xu l. Zhonghua Wai Ke Za Zhi. 2013 Apr;51(4):339-43. Zhonghua Wai Ke Za Zhi. 2013. PMID: 23895756 Chinese.

9

[A study on the predictive and evaluational value of molecular subtypes and dynamic contrast-enhanced magnetic resonance imaging of neoadjuvant chemotherapy for breast cancer].

Liu WQ, Ye JM, Xu L, Liu Q, Zhao JX, Duan XN, Liu YH. Liu WQ, et al. Among authors: xu l. Zhonghua Wai Ke Za Zhi. 2013 Aug;51(8):706-9. Zhonghua Wai Ke Za Zhi. 2013. PMID: 24252676 Chinese.

10

[Role of magnetic resonance imaging for response evaluation and predictive value of tumor biomarkers in the neoadjuvant chemotherapy for breast cancer:a multi-center prospective study].

Xin L, Liu Q, Xu L, Jiang Z, Jiang H, Qin N, Li T, Duan X, Liu Y. Xin L, et al. Among authors: xu l. Zhonghua Yi Xue Za Zhi. 2014 Jul 8;94(26):2018-21. Zhonghua Yi Xue Za Zhi. 2014. PMID: 25312661 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

42,142 results

Search Page

Filters